Target intelligence / Profile preview

Agkistrodon piscivorus venom proteins

Molecular classification
Enzyme, Metalloproteinase, Phospholipase A2, Serine protease, L-amino-acid oxidase, Disintegrin, Other
01

Overview

The venom of Agkistrodon piscivorus (Cottonmouth) is a complex mixture of proteins that function synergistically to cause systemic and local toxicity. Major components include snake venom metalloproteinases (SVMPs), which degrade the basement membrane of blood vessels leading to hemorrhage, and phospholipases A2 (PLA2s), which cause myonecrosis and inflammation (Lomonte et al., 2014). Serine proteases in the venom act as thrombin-like enzymes, depleting fibrinogen and causing venom-induced consumptive coagulopathy, while L-amino-acid oxidases contribute to tissue damage through the production of reactive oxygen species and induction of apoptosis (Sunagar et al., 2015). Disintegrins are also present, which inhibit platelet aggregation by competitively binding to the integrin alpha-IIb-beta-3 receptor (UniProt, 2023). These proteins are the primary therapeutic targets for antivenoms like CroFab and Anavip, which utilize purified antibody fragments to sequester and neutralize the toxins (FDA, 2018). Beyond their role in envenomation, these proteins have been studied as molecular templates for developing anticoagulants and anti-cancer agents due to their high specificity for physiological receptors. Clinical management of envenomation requires monitoring of hematologic parameters to assess the efficacy of neutralization. The diversity of these proteins necessitates a polyvalent approach to treatment to ensure all toxic components are addressed.

Other names
Cottonmouth venom proteinsWater moccasin venom toxinsAgkistrodon piscivorus venom proteomeAgkistrodon piscivorus venom metalloproteinases, phospholipases A2, serine proteases, L-amino-acid oxidases, disintegrins, and related venom proteins
02

Mechanism of action

Neutralization of toxic enzymatic and non-enzymatic activities through antibody binding, preventing interaction with host substrates and receptors (FDA, 2018).

03

Biological functions

ApoptosisImmune responseCell deathProteolysisLipolysisHemolysisPlatelet aggregation inhibitionOther
04

Disease associations

InflammationCardiovascular diseaseSnakebite envenomationHemorrhageCoagulopathyTissue necrosisOther
05

Safety considerations

AnaphylaxisSerum sicknessRecurrent coagulopathyIncomplete neutralization of local tissue damage
06

Interacting drugs

Crotalidae Polyvalent Immune Fab (Ovine)

1 more in the full profile.

07

Biomarkers

Fibrinogen levelsPlatelet countProthrombin time (PT)Creatine kinase (CK)

Beyond the preview

Go deeper on Agkistrodon piscivorus venom proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Agkistrodon piscivorus venom proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call